A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC)
The purpose of this study is to estimate the overall survival (OS) for US participants diagnosed with metastatic colorectal cancer (mCRC) by using Flatiron Health's individual patient level data.
Metastatic Colorectal Cancer (mCRC)
Overall Survival (OS), Up to 6 years|Duration of Systemic Treatment, Durations were reported for the first line of therapy prior to the second line (2L) therapy of interest, the 2L therapy of interest, the third line of therapy, and the at least fourth line of therapy., Up to 6 years
The purpose of this study is to estimate the overall survival (OS) for US participants diagnosed with metastatic colorectal cancer (mCRC) by using Flatiron Health's individual patient level data.